Catalyst Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Catalyst Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 86% to $398,204,000. Profit margin reached 18%. Total operating expenses were $259,425,000.
Profit Margin
| 2014 | 0 | -15.50M | |
|---|---|---|---|
| 2015 | 0 | -20.23M | |
| 2016 | 0 | -18.07M | |
| 2017 | 0 | -18.41M | |
| 2018 | 500K | -34.00M | -6800.7% |
| 2019 | 102.30M | 31.87M | 31.16% |
| 2020 | 119.07M | 74.98M | 62.97% |
| 2021 | 140.83M | 39.48M | 28.03% |
| 2022 | 214.20M | 83.07M | 38.79% |
| 2023 | 398.20M | 71.41M | 17.93% |
CPRX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 398.20M | 214.20M | 140.83M | 119.07M | 102.30M | 500K | 0 | 0 | 0 | 0 |
Cost of revenue | 84.53M | 34.39M | 21.88M | 17.03M | 14.75M | 0 | 45.68K | 0 | 34.46K | 0 |
Gross profit | 313.67M | 179.81M | 118.94M | 102.03M | 87.54M | 500K | -45.68K | 0 | -34.46K | 0 |
Operating exp. | ||||||||||
Research and development | 93.15M | 19.78M | 16.93M | 16.49M | 18.84M | 19.91M | 11.37M | 11.36M | 11.80M | 10.11M |
Selling and marketing | 86.68M | 29.46M | 26.15M | 23.56M | 3.3M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 259.42M | 77.97M | 66.56M | 60.73M | 55.72M | 35.79M | 18.67M | 19.28M | 20.39M | 14.59M |
Operating income | 86.81M | 101.83M | 52.38M | 41.30M | 31.82M | -35.29M | -18.67M | -19.28M | -20.39M | -14.59M |
Other income (expenses), net | 7.69M | 2.88M | 282K | 586.89K | 1.58M | 1.29M | 267.25K | 1.20M | 165.39K | -917.63K |
Income before tax | 94.51M | 104.71M | 52.66M | 41.89M | 33.40M | -34.00M | -18.41M | -18.07M | -20.23M | -15.50M |
Income tax expense | 23.10M | 21.64M | 13.18M | -33.09M | 1.53M | 2.58M | 141.21K | -929.54K | -99.47K | 993.86K |
Net income | 71.41M | 83.07M | 39.48M | 74.98M | 31.87M | -34.00M | -18.41M | -18.07M | -20.23M | -15.50M |
Earnings per share | ||||||||||
Basic EPS | 0.67 | 0.8 | 0.38 | 0.72 | 0.31 | -0.33 | -0.21 | -0.22 | -0.25 | -0.24 |
Diluted EPS | 0.63 | 0.75 | 0.37 | 0.71 | 0.3 | -0.33 | -0.21 | -0.22 | -0.25 | -0.24 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |